Low Dose Carboplatin Combined With Angiostatic Agents Prevents Metastasis in Human Testicular Germ Cell Tumor Xenografts
Author:
Affiliation:
1. From the Laboratory for Cardiovascular Research, Department of Anatomy, University of Vienna (DA, SA, MH, SA) and Division of Urology, KFJ-Hospital (WH), Vienna, Austria
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference16 articles.
1. Testicular germ-cell cancer;Bosl;N Engl J Med,1997
2. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study;Bajorin;J Clin Oncol,1993
3. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study;Tscherry;Oncology,2000
4. Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor;Aharinejad;J Urol,2002
5. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease;Teicher;Cancer Res,1992
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A mathematical model to study low-dose metronomic scheduling for chemotherapy;Mathematical Biosciences;2024-06
2. Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities;Cancer Treatment Reviews;2020-08
3. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities;Cancer Treatment Reviews;2020-08
4. Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma;Cancer Management and Research;2019-04
Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma
5. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications;Current Cancer Drug Targets;2018-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3